BBA
Baker Bros. Advisors’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.9M | Hold |
2,322,656
| – | – | 0.71% | 19 |
|
|
2025
Q1 | $68.9M | Buy |
2,322,656
+807,338
| +53% | +$24M | 0.76% | 16 |
|
|
2024
Q4 | $44.7M | Hold |
1,515,318
| – | – | 0.48% | 26 |
|
|
2024
Q3 | $47.2M | Hold |
1,515,318
| – | – | 0.49% | 25 |
|
|
2024
Q2 | $51.4M | Hold |
1,515,318
| – | – | 0.66% | 24 |
|
|
2024
Q1 | $98.5M | Sell |
1,515,318
-1,005,413
| -40% | -$65.4M | 1.24% | 11 |
|
|
2023
Q4 | $172M | Hold |
2,520,731
| – | – | 1.96% | 7 |
|
|
2023
Q3 | $131M | Hold |
2,520,731
| – | – | 0.75% | 9 |
|
|
2023
Q2 | $151M | Hold |
2,520,731
| – | – | 0.87% | 7 |
|
|
2023
Q1 | $125M | Hold |
2,520,731
| – | – | 0.68% | 7 |
|
|
2022
Q4 | $144M | Hold |
2,520,731
| – | – | 0.86% | 10 |
|
|
2022
Q3 | $118M | Buy |
2,520,731
+1
| +0% | +$47 | 0.77% | 11 |
|
|
2022
Q2 | $94M | Hold |
2,520,730
| – | – | 0.53% | 14 |
|
|
2022
Q1 | $75.4M | Hold |
2,520,730
| – | – | 0.43% | 19 |
|
|
2021
Q4 | $86.3M | Hold |
2,520,730
| – | – | 0.42% | 21 |
|
|
2021
Q3 | $93.4M | Hold |
2,520,730
| – | – | 0.41% | 20 |
|
|
2021
Q2 | $98.4M | Hold |
2,520,730
| – | – | 0.43% | 21 |
|
|
2021
Q1 | $107M | Buy |
+2,520,730
| New | +$107M | 0.47% | 19 |
|